97-9993. Submission of OMB Review; Comment Request; Women's Health Initiative Observational Study  

  • [Federal Register Volume 62, Number 75 (Friday, April 18, 1997)]
    [Notices]
    [Pages 19121-19122]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 97-9993]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    National Institutes of Health
    
    
    Submission of OMB Review; Comment Request; Women's Health 
    Initiative Observational Study
    
    SUMMARY: Under the provisions of Section 3506(c)(2)(A) of the Paperwork
    
    [[Page 19122]]
    
    Reduction Act of 1995, the Office of the Director (OD), National 
    Institutes of Health (NIH), has submitted to the Office of Management 
    and Budget (OMB) a request for review and approval of the information 
    collection listed below. This proposed information collection was 
    previously published in the Federal Register on November 4, 1996 
    (Volume 61, Number 214, Page 56696) and allowed 60-days for public 
    comment. No public comments were received. The purpose of this notice 
    is to allow an additional 30 days for public comment. The National 
    Institutes of Health may not conduct or sponsor, and the respondent is 
    not required to respond to, an information collection that has been 
    extended, revised or implemented on or after October 1, 1995 unless it 
    displays a currently valid OMB control number.
    
    PROPOSED COLLECTION: Title: Women's Health Initiative (WHI) 
    Observational Study. Type of Information Collection Request: Revision 
    of OMB #0925-0414. Exp: 6/30/97. Need for Use of Information 
    Collection: This study will be used by NIH to evaluate risk factors for 
    chronic disease among older women by developing and following a large 
    cohort of postmenopausal women and relating subsequent disease 
    development to baseline assessments of historical, physical, 
    psychosocial, and physiologic characteristics. In addition, the 
    observational study will complement the clinical trial (which has 
    received clinical exemption) and provide additional information on the 
    common cause of frailty, disability and health for postmenopausal 
    women, namely, coronary heart disease, breast and colorectal cancer, 
    and osteoporotic fractures. Frequency of Response: On occasion. 
    Affected Public: Individuals and physicians. Type of Respondents: 
    Women, next of kin, and physicians. The annual reporting burden is as 
    follows:
    
    ----------------------------------------------------------------------------------------------------------------
                                                                               Estimated                  Estimated 
                                                                 Estimated     number of      Average       total   
                        Type of respondents                      number of     responses   burden hours     annual  
                                                                respondents       per      per response     hours   
                                                                              respondent                  requested 
    ----------------------------------------------------------------------------------------------------------------
    OS Participants...........................................      100,000       1.06667         .819        87,360
    Next-of-Kin...............................................        2,682       1               .0835          224
    Physician.................................................          166       1               .0835           14
                                                               -----------------------------------------------------
          Total...............................................  ...........  ............  ............       87,598
    ----------------------------------------------------------------------------------------------------------------
    
        The annualized cost to respondents is: $876,525.
        There are no annual Capital Costs, Operating Costs, and/or 
    Maintenance Costs to report.
    
    Request for Comments
    
        Written comments and/or suggestions from the public and affected 
    agencies should address one or more of the following points: (1) 
    Evaluate whether the proposed collection is necessary for the proper 
    performance of the functions of the agency, including whether the 
    information will have practical utility; (2) Evaluate the accuracy of 
    the agency's estimate of the burden of the proposed collection of 
    information, including the validity of the methodology and assumptions 
    used; (3) Enhance the quality, utility, and clarity of the information 
    to be collected; and (4) Minimize the burden of the collection of 
    information on those who are to respond, including through the use of 
    appropriate automated, electronic, mechanical, or other technological 
    collection techniques or other forms of information technology.
    
    Direct Comments to OMB
    
        Written comments and/or suggestions regarding item(s) contained in 
    this notice, especially regarding the estimated public burden and 
    associated response time, should be directed to the: Office of 
    Management and Budget, Office of Regulatory Affairs, New Executive 
    Office Building, Room 10235, Washington, D.C. 20503, Attention: Desk 
    Officer for NIH. to request more information on the proposed project or 
    to obtain a copy of the data collection plan and instruments, contact: 
    Dr. Loretta Finnegan, Women's Health Initiative Program Office, 7550 
    Rockville Pike, Room 6A09, Bethesda, Maryland 20892-9110 or call non-
    toll-free number (301) 402-2900, or E-mail your request, including your 
    address to: .
    
    COMMENTS DUE DATE: Comments regarding this information collection are 
    best assured of having their full effect if received on or before May 
    19, 1997.
    
        Dated: March 11, 1997.
    Stephen Benowitz,
    Executive Officer, Office of the Director, NIH.
    [FR Doc. 97-9993 Filed 4-17-97; 8:45 am]
    BILLING CODE 4140-01-M
    
    
    

Document Information

Effective Date:
5/19/1997
Published:
04/18/1997
Department:
National Institutes of Health
Entry Type:
Notice
Document Number:
97-9993
Dates:
Comments regarding this information collection are best assured of having their full effect if received on or before May 19, 1997.
Pages:
19121-19122 (2 pages)
PDF File:
97-9993.pdf